Valuation: Bio-Techne Corporation

Capitalization 9.39B 8.09B 7.59B 7.06B 13.01B 847B 14.19B 88.46B 34.25B 400B 35.26B 34.5B 1,465B P/E ratio 2026 *
47x
P/E ratio 2027 * 40.7x
Enterprise value 9.34B 8.04B 7.55B 7.01B 12.93B 842B 14.1B 87.92B 34.05B 397B 35.04B 34.29B 1,456B EV / Sales 2026 *
7.63x
EV / Sales 2027 * 6.88x
Free-Float
99.46%
Yield 2026 *
0.53%
Yield 2027 * 0.53%
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.25%
1 week-5.44%
Current month-6.54%
1 month+5.02%
3 months+11.42%
6 months+23.82%
Current year-16.30%
More quotes
1 week 59.95
Extreme 59.95
64.72
1 month 56.97
Extreme 56.97
66.06
Current year 46.01
Extreme 46.01
79.28
1 year 46.01
Extreme 46.01
79.28
3 years 46.01
Extreme 46.01
89.91
5 years 46.01
Extreme 46.01
135.96
10 years 19.99
Extreme 19.9875
135.96
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 31/01/2024
Director of Finance/CFO 54 31/03/2014
Investor Relations Contact - 30/09/2019
Director TitleAgeSince
Chairman 69 01/11/2012
Director/Board Member 55 18/05/2009
Director/Board Member 62 25/10/2017
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.25%-5.44%-19.08%-26.43% 9.39B
+0.99%-1.19%+5.06%+20.04% 47.68B
-1.01%-2.14%+10.33%+6.25% 38.07B
+1.11%-2.71%+58.78%+62.61% 36.13B
+2.07%+0.70%+13.44%+20.39% 27.89B
+0.19%-6.60%+56.67%+161.68% 15.47B
+0.53%+5.62%+66.55%+223.47% 15.48B
-2.03%+1.33%-16.26%-8.26% 13.91B
+0.50%+4.01%+52.74% - 13.71B
-0.21%-0.59%+113.88%+114.50% 13.2B
Average -0.01%-0.61%+34.21%+63.81% 23.09B
Weighted average by Cap. +0.31%-0.84%+29.71%+51.25%
See all sector performances

Financials

2026 *2027 *
Net sales 1.22B 1.05B 989M 920M 1.7B 110B 1.85B 11.53B 4.46B 52.12B 4.6B 4.5B 191B 1.31B 1.13B 1.06B 983M 1.81B 118B 1.98B 12.32B 4.77B 55.71B 4.91B 4.81B 204B
Net income 202M 173M 163M 151M 279M 18.17B 304M 1.9B 735M 8.58B 756M 740M 31.43B 235M 203M 190M 177M 326M 21.22B 355M 2.22B 858M 10.02B 883M 864M 36.7B
Net Debt -57.07M -49.13M -46.12M -42.87M -79.02M -5.14B -86.21M -537M -208M -2.43B -214M -210M -8.9B -390M -335M -315M -293M -540M -35.13B -589M -3.67B -1.42B -16.59B -1.46B -1.43B -60.77B
More financial data * Estimated data
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (71.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.4%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.3%). Net sales are distributed geographically as follows: the United States (56%), the United Kingdom (4.5%), Europe/Middle East/Africa (21.8%), China (8.3%), Asia/Pacific (6.3%) and other (3.1%).
Employees
3,100
More about the company
Date Price Change Volume
08/12/25 60.29 $ -2.25% 2,070,615
05/12/25 61.68 $ -2.93% 1,764,985
04/12/25 63.54 $ -0.44% 1,442,714
03/12/25 63.82 $ +1.38% 1,783,107
02/12/25 62.95 $ -1.27% 1,368,627

Delayed Quote Nasdaq, December 08, 2025 at 09:00 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
60.29USD
Average target price
69.17USD
Spread / Average Target
+14.72%
Consensus

Quarterly revenue - Rate of surprise